TMEM37 and leukemia: As CB-8F4CAR-iNK T cells are predominantly CD4+, we carefully evaluated their cytolytic activity against PR1/HLA-A2+ or αGalCer/CD1d+ leukemia and compared those with AD-8F4CAR-iNK T cells derived from multiple donors.